Assessment of hepatic fibrosis, portal hemodynamic changes, and disease severity in patients with HCV-related liver cirrhosis after sustained virologic response to direct-acting antiviral drugs (DAAs)

Egyptian Liver Journal

Table 1 Baseline clinical data of our patients

Item	Descriptive “n = 100”
-Age “years”
Mean ± SD	60.9 ± 8.81 (36–80)
-Sex
Male	65 (65%)
Female	35 (35%)
-Smoking	57 (57%)
-Comorbidity
Diabetes mellitus	25 (25%)
Hypertension	27 (27%)
-Treatment regimen
SOF\DCV\RBV 12 weeks	89 (89%)
SOF\DCV 24 weeks	11 (11%)
-Baseline upper endoscopy (26 patients)
Normal	11 (42.3%)
Varices	13 (50%)
Portal hypertensive gastropathy	2 (7.69%)